Saturday, 13 April 2024

Singapore-based startup Genetica launches decentralised science platform for precision medicine

24 February 2023 | News

To empower billions of people to join forces for the advancement of precision medicine

Singapore-based artificial intelligence (AI) biotech company Genetica has launched the decentralised science platform GenomicDAO to empower billions of people to join forces for the advancement of Precision Medicine.

GenomicDAO breaks free from the centralisation of modern medicine R&D by establishing a community that initiates, drives, and governs precision medicine initiatives. Members are incentivised for supporting GenomicDAO precision medicine initiatives. GenomicDAO revenue derives from direct-to-consumer products. Proceeds from the marketplace are then used to buy back GenomicDAO tokens, thereby increasing the value of the project exponentially and benefiting investors.

The startup has kicked off its first initiative - Stroke Prevention with its governance and utility token listing. Stroke-Prevention GenomicDAO presents its unique BEP20-based governance and utility token $PCSP, which allows investors to become rightful stakeholders, participate in GenomicDAO’s liquidity, and receive active voting power on significant business direction, reaping the financial and medical benefits and successes.

A PCSP token, a BEP20-based security token, is a digital asset purpose-built for our platform. $PCSP tokens are a payment method, a means for investors to receive rewards from liquidity and special programs, and a way to exercise voting rights.

Stroke Prevention is the first subsidiary DAO under the GenomicDAO ecosystem to help create awareness and initiate R&D for ischemic stroke.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account